It makes recommendations on insulin regimens for improving glycemic control, emphasizes the importance of continuing long-acting basal insulin in patients who are on this at admission, and mentions the use of liquid metformin through the feeding tube for mild hyperglycemia in patients with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.